rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Janet Dillione

Director

Company insider

Files Form 4 as: Director, CorMedix; Executive VP and GM Healthcare, Nuance Communications.

Every Form 4 they filed

In numbers

Trades disclosed
112
Buys
7
Sells
8
Bought
$281K
Sold
$3.8M
Companies
2
Companies where not an officer
1
First trade
30 Jun 2010
Last trade
18 Sep 2026
Last filed
18 Sep 2026

Companies traded

Where they are an officer
Nuance CommunicationsOfficer · last 6 Dec 20130 buys · 3 sells
Everywhere else they filed: board seats, 10% stakes, other companies
CRMD CorMedixDirector · Pharmaceuticals · last 18 Sep 20267 buys · 5 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
20Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
18 Sep 2026filed 18 Sep 2026CRMD CorMedixPharmaceuticalsSEC FORM 4 Code M—48,909filing
18 Sep 2026filed 18 Sep 2026CRMD CorMedixoption or derivative · PharmaceuticalsSEC FORM 4 Code M—48,909filing
18 Sep 2026filed 18 Sep 2026CRMD CorMedixoption or derivative · PharmaceuticalsSEC FORM 4 Code M—48,909filing
18 Sep 2026filed 18 Sep 2026CRMD CorMedixPharmaceuticalsSEC FORM 4 Code M—48,909filing
26 Jan 2026filed 27 Jan 2026CRMD CorMedixPharmaceuticalsSEC FORM 4 Code A—30,453 at $0.00filing
26 Jan 2026filed 27 Jan 2026CRMD CorMedixPharmaceuticalsSEC FORM 4 Code A—30,453 at $0.00filing
21 Jan 2026filed 22 Jan 2026CRMD CorMedixPharmaceuticalsSEC FORM 4 Sold$69K10,000 at $6.88filing
21 Jan 2026filed 22 Jan 2026CRMD CorMedixPharmaceuticalsSEC FORM 4 Sold$69K10,000 at $6.88filing
9 Dec 2025filed 11 Dec 2025CRMD CorMedixoption or derivative · PharmaceuticalsSEC FORM 4 Code M—19,000 at $0.00filing
9 Dec 2025filed 11 Dec 2025CRMD CorMedixoption or derivative · PharmaceuticalsSEC FORM 4 Code M—15,000 at $0.00filing
9 Dec 2025filed 11 Dec 2025CRMD CorMedixPharmaceuticalsSEC FORM 4 Code M$181K19,000 at $9.55filing
9 Dec 2025filed 11 Dec 2025CRMD CorMedixPharmaceuticalsSEC FORM 4 Code M$84K15,000 at $5.63filing
9 Dec 2025filed 11 Dec 2025CRMD CorMedixPharmaceuticalsSEC FORM 4 Sold$408K34,000 at $12.00filing
2 Dec 2025filed 4 Dec 2025CRMD CorMedixoption or derivative · PharmaceuticalsSEC FORM 4 Code M—12,210 at $0.00filing
2 Dec 2025filed 4 Dec 2025CRMD CorMedixoption or derivative · PharmaceuticalsSEC FORM 4 Code M—15,124 at $0.00filing
2 Dec 2025filed 4 Dec 2025CRMD CorMedixoption or derivative · PharmaceuticalsSEC FORM 4 Code M—19,323 at $0.00filing
2 Dec 2025filed 4 Dec 2025CRMD CorMedixPharmaceuticalsSEC FORM 4 Code M$49K12,210 at $4.03filing
2 Dec 2025filed 4 Dec 2025CRMD CorMedixPharmaceuticalsSEC FORM 4 Code M$67K15,124 at $4.43filing
2 Dec 2025filed 4 Dec 2025CRMD CorMedixPharmaceuticalsSEC FORM 4 Code M$69K19,323 at $3.55filing
2 Dec 2025filed 4 Dec 2025CRMD CorMedixPharmaceuticalsSEC FORM 4 Sold$467K46,657 at $10.00filing

News

Contrasting CorMedix (NASDAQ:CRMD) & InMed Pharmaceuticals (NASDAQ:INM)CRMD · themarketsdaily.com · 22 Oct 2026Head-To-Head Survey: Inhibikase Therapeutics (NASDAQ:IKT) versus CorMedix (NASDAQ:CRMD)CRMD · themarketsdaily.com · 10 Oct 2026

0 headlines in the last 90 days name Janet Dillione; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.

Sectors

Health Care12
Not placed3

Buys in green, sells in red, by the company’s sector.

Related people

Nobody else traded the same names lately.